Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMPRSS4 | Q9NRS4 | 6/20 | 1.00 |
| ▸ | P2RX1 | P51575 | 12/20 | 0.81 |
| ▸ | P2RX4 | Q99571 | 5/20 | 0.79 |
| ▸ | P2RX7 | Q99572 | 5/20 | 0.79 |
| ▸ | KCNMA1 | Q12791 | 3/20 | 0.72 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.66 |
| ▸ | FADS1 | O60427 | 1/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.64 |
| ▸ | MEN1 | O00255 | 1/20 | 0.64 |
| ▸ | LMNA | P02545 | 1/20 | 0.64 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
| ▸ | HPGD | P15428 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18341403 | 0.93 | TMPRSS4 (0.86) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL29024720 | 0.91 | TMPRSS4 (0.83) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL2169619 | 0.90 | P2RX1 (1.00) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL29454776 | 0.90 | P2RX1 (1.00) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL11932152 | 0.89 | P2RX1 (1.00) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL13812568 | 0.88 | TMPRSS4 (0.78) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL329189 | 0.88 | TMPRSS4 (0.78) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL24438034 | 0.87 | TMPRSS4 (0.76) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL24438367 | 0.87 | TMPRSS4 (0.76) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 | |
| SCHEMBL24438295 | 0.87 | TMPRSS4 (0.76) | TMPRSS4P2RX1P2RX4P2RX7KCNMA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 311 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | claimed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | claimed |
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | DUKE UNIVERSITY | 2020-02-06 | — | — | US | claimed |
| EP-3313388-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | Duke University (US) | 2018-05-02 | — | — | EP | claimed |
| WO-2016210289-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | DUKE UNIVERSITY (US) | 2016-12-29 | — | — | WO | claimed |
| US-20140221411-A1 | 2-HYDROXYARYLAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2014-08-07 | — | — | US | claimed |
| US-20070148185-A1 | Novel therapeutic target for protozoal diseases | VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY | 2007-06-28 | — | — | US | claimed |
| WO-2007047579-A2 | A NOVEL THERAPEUTIC TARGET FOR PROTOZOAL DISEASES | VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. (US) | 2007-04-26 | — | — | WO | claimed |
| EP-1349453-A2 | BIOCIDE COMPOSITIONS AND METHODS AND SYSTEMS EMPLOYING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2003-10-08 | — | — | EP | claimed |
| US-20020068014-A1 | Antibacterial agents and compositions, methods and systems employing same | PROCTER & GAMBLE COMPANY, THE | 2002-06-06 | — | — | US | claimed |
| US-20020014178-A1 | Biocide compositions and methods and systems employing same | PROCTER & GAMBLE COMPANY, THE | 2002-02-07 | — | — | US | claimed |
| WO-2002005643-A2 | BIOCIDE COMPOSITIONS AND METHODS AND SYSTEMS EMPLOYING SAME | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-24 | — | — | WO | claimed |
| WO-2001060157-A2 | ANTIBACTERIAL AGENTS AND COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 2001-08-23 | — | — | WO | claimed |
| US-4983569-A | Color-forming layer comprising a fluorene dye chromogen, a developer, an isocyanate and an imino compound; infrared absorption; storage stability; colorfastness | MITSUBISHI PAPER MILLS (JP) | 1991-01-08 | — | — | US | claimed |
| US-4845072-A | COLORING LAYER COMPRISING A LEUCO DYE, A COLOR DEVELOPER AND A VINYL ETHER COMPOUND | RICOH COMPANY, LTD. (JP) | 1989-07-04 | — | — | US | claimed |
| US-4731354-A | ARYL DIETHER SOLVENT | RICOH COMPANY, LTD. (JP) | 1988-03-15 | — | — | US | claimed |
| JP-59124885-A | — | — | None | — | — | JP | disclosed |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY INC (US) | 2026-04-02 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| JP-S59124885-A | HEAT-SENSITIVE RECORDING MATERIAL | RICOH CO LTD | 1984-07-19 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020068014-A1 | Antibacterial agents and compositions, methods and systems employing same | SPOUT1, PGLS, TLR6 | TMPRSS4 2344/4885P2RX1 2786/4885P2RX4 2898/4885 |
| US-20260091043-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | AHCY, MACO1, ME3 | TMPRSS4 2198/4885P2RX1 2635/4885P2RX4 3093/4885 |
| US-20200038350-A1 | CHEMICAL MODULATORS OF SIGNALING PATHWAYS AND THERAPEUTIC USE | SFRP1, FZD7, WNT1 | TMPRSS4 2074/4885P2RX1 3423/4885P2RX4 3784/4885 |
| US-20140221411-A1 | 2-HYDROXYARYLAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT | TMPRSS2, TMPRSS4, PRSS2 | TMPRSS4 2/4885P2RX1 4273/4885P2RX4 3330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.